ANDO GORAN has filed 5 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 41500 shares of EyePoint, Inc. ($EYPT) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | EyePoint, Inc. | $EYPT | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 41500 | $0.00 | 41,500.0000 | 82,787,220 | 9999.99% | 0.05% |
| Jan. 3, 2025 | EyePoint, Inc. | $EYPT | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 41500 | $0.00 | 41,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 21, 2024 | EyePoint, Inc. | $EYPT | ANDO GORAN | Not found | P | Common Stock | 5000 | $7.95 | 13,150.0000 | 0 | 61.35% | 0.00% |
| Jan. 5, 2024 | EyePoint, Inc. | $EYPT | ANDO GORAN | Not found | A | Stock Option (Right to Buy) | 23598 | $0.00 | 23,598.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | ANDO GORAN | Director | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 5,101,459 | 9999.99% | 1.47% |